SOADOR
NAGE

State of Alaska Department of Revenue’s Niagen Bioscience NAGE Stock Holding History

State of Alaska Department of Revenue’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91K Hold
28,775
– – ﹤0.01% 1802
2026
Q1 		$126K Hold
28,775
– – ﹤0.01% 1723
2025
Q4 		$182K Buy
28,775
+23,977
+500% +$167K ﹤0.01% 1679
2025
Q3 		$44K Buy
+4,798
New +$48.4K ﹤0.01% 1819

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

State of Alaska Department of Revenue's NAGE Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Niagen Bioscience (NAGE) position steady in Q2 2026 at 28,775 shares worth $91K. The position accounts for ﹤0.01% of the portfolio, ranked #1802.

State of Alaska Department of Revenue first reported a position in NAGE in Q3 2025 and has held it in 4 quarters since. The position peaked at $182K in Q4 2025. 78 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • State of Alaska Department of Revenue held 28,775 shares of Niagen Bioscience worth $91K as of Q2 2026.
  • State of Alaska Department of Revenue left its Niagen Bioscience share count unchanged in Q2 2026.
  • Niagen Bioscience made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1802 holding.
  • State of Alaska Department of Revenue first reported a position in Niagen Bioscience in Q3 2025 and has held it in 4 quarters since.
  • State of Alaska Department of Revenue's Niagen Bioscience position peaked at $182K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.